Horning, S. 2009. Bevacizumab as an anti-VEGF strategy in lymphoma. Hematology Meeting Reports (formerly Haematologica Reports). 2, 5 (Jun. 2009). DOI:https://doi.org/10.4081/hmr.v2i5.739.